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Embryonic multipotent neural precursors are
exposed to extracellular signals instructing
them to adopt different fates, neuronal or glial.
However, the mechanisms by which precursors
integrate these signals to make timely fate
choices remained undefined. Here we show that
direct nuclear signaling by a receptor tyrosine
kinase inhibits the responses of precursors to
astrocyte differentiation factors while maintain-
ing their neurogenic potential. Upon neuregulin-
induced activation and presenilin-dependent
cleavage of ErbB4, the receptor’s intracellular
domain forms a complex with TAB2 and the
corepressor N-CoR. This complex undergoes
nuclear translocation and binds promoters of
astrocytic genes, repressing their expression.
Consistent with this observation, astrogenesis
occurs precociously in ErbB4 knockout mice.
Our studies define how presenilin-dependent
nuclear signaling by a receptor tyrosine kinase
directly regulates gene transcription and cell
fate. This pathway could be of importance for
neural stem cell biology and for understanding
the pathogenesis of Alzheimer’s disease.
INTRODUCTION
Regulation of gene transcription by receptor tyrosine ki-
nases (RTKs) plays essential roles in many cellular pro-
cesses. Until recently, these receptors were believed to
regulate transcription only via the activation of a multilay-
ered network of kinase cascades that phosphorylate
transcription factors, altering their activity (Schlessinger,
2000). However, recent studies on ErbB4, a member of
the EGF receptor family, suggest that some RTKs may sig-
nal directly to the cell nucleus via a novel signaling mech-
anism that does not depend on kinase cascades but
rather requires receptor phosphorylation, intramembraneproteolysis, and nuclear translocation of the RTK intracel-
lular domain (Lee et al., 2002; Ni et al., 2001).
Neuregulin 1 (NRG1) stimulation of ErbB4 promotes
receptor ectodomain cleavage by the metalloprotease
TNF-a-converting enzyme (TACE) (Rio et al., 2000). The
cell-associated fragment containing the transmembrane
and cytoplasmic domains is subsequently cleaved by
presenilin/g-secretase, releasing its intracellular domain
(E4ICD) into the cytosol. E4ICD can then translocate to
the nucleus (Ni et al., 2001). The potential biological signif-
icance of the proteolytic cleavage of ErbB4 is underscored
by two facts. First, ErbB4 appears to be the only member
of the ErbB family to be processed by proteases in this
fashion and to harbor a functional nuclear localization sig-
nal in its intracellular domain (Carpenter, 2003). Second,
alternative splicing of the ErbB4 gene generates two
isoforms that differ in their extracellular juxtamembrane
(JM) regions, their sensitivity to proteolytic cleavage
(Elenius et al., 1997), and therefore their ability to signal
through regulated intramembrane proteolysis. Whereas
ErbB4 JMa, the originally described isoform of ErbB4
(Plowman et al., 1993), is sensitive to cleavage by TACE
and presenilin, the ErbB4 JMb isoform is not. Interestingly,
these isoforms have different expression patterns, indicat-
ing that proteolytic cleavage of ErbB4, and therefore its
nuclear signaling, is specific to certain tissues, in parti-
cular the brain, where ErbB4 JMa is highly expressed
(Elenius et al., 1997). These observations suggested that
ErbB4 cleavage and E4ICD nuclear translocation could
play important roles in the brain, but its functions and
mechanisms of action remained to be identified.
Here we show that NRG1-induced presenilin-depen-
dent ErbB4 nuclear signaling regulates the timing of astro-
genesis in the developing brain. Upon activation and
presenilin-dependent cleavage of ErbB4, E4ICD forms
a complex with the signaling protein TAB2 and the core-
pressor N-CoR. This complex translocates to the nucleus
of undifferentiated neural precursors and inhibits their dif-
ferentiation into astrocytes by repressing the transcription
of glial genes. Consistent with this observation, cortical
astrogenesis occurs precociously in ErbB4 knockout em-
bryos, a phenotype that is rescued by re-expression of hu-
man ErbB4 JMa but not by the uncleavable ErbB4 JMb.Cell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc. 185
Figure 1. Activated E4ICD Interacts with TAB2 in Yeast and Mammalian Cells
(A) E4ICD becomes phosphorylated in yeast. Yeast expressing wild-type (WT) and kinase-dead (KD) LexA-E4ICD fusion proteins were lysed and
immunoblotted with ErbB4 or phosphotyrosine (P-Y) antibodies, showing that both proteins are expressed (top panel) but only the WT is tyrosine
phosphorylated (bottom panel).
(B) Schematic diagram of TAB2. Regions of TAB2 included in two clones identified in the screen are indicated. zf-Ran BD: zinc finger Ran-binding
domain.
(C) Tyrosine kinase activity of E4ICD is necessary for interaction with TAB2 in yeast. WT or KD LexA-E4ICD was coexpressed in yeast with full-length
TAB2 or PDZ domains 1 and 2 of PSD-95 (Huang et al., 2000) as fusion proteins with the B42 activation domain. TAB2 only interacts with phosphor-
ylated E4ICD (blue color), whereas PSD-95 interacts with both baits.
(D) ErbB4/TAB2 interaction in mammalian cells depends on receptor activation. Full-length ErbB4 WT or KD was transfected into HEK293 cells to-
gether with full-length FLAG-TAB2. Cells were left untreated or were treated with NRG1, lysed, and immunoprecipitated with ErbB4 antibody followed
by immunoblotting with FLAG antibody. Whole-cell lysates were also immunoblotted with ErbB4, phosphotyrosine (P-Y), and FLAG antibodies to
characterize the input.Our studies define how presenilin-dependent nuclear sig-
naling by an RTK directly regulates gene transcription and
cell fate in the developing brain.
RESULTS
Identification of Proteins that Interact
with Activated E4ICD
Since the E4ICD has no known DNA-binding or transcrip-
tional activation motifs, we hypothesized that ErbB4-bind-
ing proteins that are involved in transcriptional regulation
should exist and that their interaction with ErbB4 might
depend on its activation. To identify such proteins, we
used a yeast two-hybrid system that facilitates the isola-
tion of proteins that interact with activated RTKs (Qian
et al., 1998). Screening of a cDNA expression library
from rat embryonic day 14 (E14) spinal cord and dorsal
root ganglia with a bait containing the entire E4ICD in an
activated state (Figure 1A) led to isolation of several puta-
tive E4ICD-interacting proteins. Among them, two clones186 Cell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc.contained cDNAs encoding the C-terminal region of TAB2
(TAK1 binding protein 2; Figure 1B), a protein first identi-
fied as an adaptor for TAK1 (transforming growth factor
b-activated kinase 1) (Takaesu et al., 2000). Wild-type
E4ICD also interacted with full-length TAB2 in yeast, and
this association was abolished when the tyrosine kinase
activity of E4ICD was eliminated by a mutation in the
ATP-binding site (E4ICDKD) (Figure 1C). Thus, binding of
TAB2 to ErbB4 in yeast appears to occur only when the
receptor is activated.
We then tested whether TAB2 also binds to ErbB4 in
mammalian cells and whether this interaction depends
on receptor activation by NRG1, an ErbB4 ligand. Cells
were cotransfected with FLAG-TAB2 and full-length
ErbB4 expression constructs and then subjected to im-
munoprecipitation with ErbB4 antibodies. TAB2 copreci-
pitated with ErbB4 only after NRG1 treatment (Figure 1D).
In contrast, full-length kinase-dead ErbB4 failed to interact
with TAB2 even in the presence of NRG1, indicating that
ligand binding is not sufficient to induce TAB2/ErbB4
association (Figure 1D). These results show that ErbB4
and TAB2 interact in mammalian cells and that this asso-
ciation requires receptor activation.
Presenilin-Dependent Cleavage of ErbB4 Promotes
TAB2 Nuclear Translocation
The dependence of ErbB4/TAB2 interaction on NRG1
suggested that ErbB4 activation could alter TAB2, partic-
ularly its state of phosphorylation or its cellular localiza-
tion. Phosphotyrosine western blot and 32P incorporation
assays in cells expressing ErbB4 did not demonstrate
induction of TAB2 phosphorylation by NRG1 (data not
shown). Furthermore, no shift of the TAB2 band was ob-
served on western blots in response to NRG1 (Figure 1D).
Thus, it appears that ErbB4 activation does not induce
TAB2 phosphorylation. In contrast, NRG1-ErbB4 signal-
ing had dramatic effects on the cellular distribution of
TAB2. In quiescent NIH 3T3 cells, TAB2 was excluded
from the nuclei independently of whether the cells ex-
pressed ErbB4 or not. Notably, upon stimulation with
NRG1, TAB2 translocated to the nucleus in cells express-
ing ErbB4 (Figure 2A).
In the experiments described above, we used ErbB4
JMa, the splice variant that undergoes proteolytic cleav-
age after activation (Elenius et al., 1997). To determine
whether NRG1-induced TAB2 nuclear translocation de-
pends on ErbB4 cleavage, we tested whether TAB2 shut-
tling also occurs in cells that express the naturally occur-
ring TACE-resistant isoform ErbB4 JMb. In contrast to
ErbB4 JMa, NRG1 did not induce TAB2 nuclear transloca-
tion in cells expressing ErbB4 JMb (Figure 2B), even
though this uncleavable isoform interacted with TAB2
upon NRG1 stimulation (data not shown). Furthermore,
the NRG1-induced nuclear translocation of TAB2 in
ErbB4 JMa-expressing cells was eliminated by the prese-
nilin inhibitor DAPT (Dovey et al., 2001) (Figure 2B). More-
over, ErbB4 JMaKD failed to induce TAB2 nuclear shuttling
even in the presence of NRG1 (Figure 2B). These results
show that NRG1-induced activation of ErbB4 JMa and
the ensuing sequential proteolytic cleavage by TACE and
presenilin are important for TAB2 nuclear translocation.
The ErbB4-dependent TAB2 nuclear translocation
raised the possibility that TAB2 could be mediating poten-
tial effects of E4ICD on gene expression. We tested this
using a GAL4/TAB2 fusion protein and a UAS-TK-lucifer-
ase reporter. The basal activity of this reporter in unstimu-
lated cells is moderate, but it can be either increased or
decreased by transcriptional activators or repressors
(Chen and Evans, 1995). Treating cells expressing ErbB4
JMa and GAL4/TAB2 with NRG1 significantly reduced
UAS-TK-directed luciferase activity (Figure 2C). In con-
trast, NRG1 had no effects onUAS-TK-directed luciferase
activity when cells expressed ErbB4 JMb or when the
ErbB4 JMa-expressing cells were exposed to DAPT (Fig-
ure 2C). These findings provided further evidence that
NRG1-mediated ErbB4 activation and cleavage induces
nuclear translocation of TAB2 and raised the possibility
that an E4ICD/TAB2 complex represses transcription.Given that TAB2 can form a complex with the transcrip-
tional corepressor N-CoR (Baek et al., 2002), we tested
whether N-CoR also interacts with ErbB4. Cells were
transfected with full-length ErbB4 or ErbB4KD, treated
with NRG1, and immunoprecipitated with ErbB4 anti-
bodies. As with TAB2, only wild-type ErbB4 coimmuno-
precipitated with endogenous N-CoR, and this occurred
only when the cells were stimulated with NRG1 (Figure 2D).
No tyrosine phosphorylation of N-CoR was detected when
ErbB4 was activated (data not shown). These results show
that NRG1 induces the formation of an E4ICD/TAB2/
N-CoR complex.
We then probed the roles of TAB2 in the interaction be-
tween E4ICD and N-CoR. First, we asked whether ErbB4
could bind to N-CoR in the absence of TAB2 using RNAi.
Lack of TAB2 expression abolished the NRG1-dependent
E4ICD/N-CoR association, suggesting that TAB2 forms
the bridge between E4ICD and N-CoR (Figure 2E). We
also used truncated versions of TAB2 to define the spe-
cific domains within this protein responsible for its ability
to link E4ICD to N-CoR. As expected from the portion of
TAB2 that binds to E4ICD in the yeast two-hybrid assay
(Figure 1B), a truncated TAB2 lacking its C-terminal end
(TAB2DC) failed to coprecipitate with activated ErbB4
(Figure 2F), indicating that the C-terminal 64 amino acids
of TAB2 are not only sufficient but also necessary for
ErbB4/TAB2 interaction. In contrast, TAB2 binds constitu-
tively to N-CoR (Figure 2G). Furthermore, N-CoR physi-
cally interacts with TAB2DC but not with TAB2DN, the
C-terminal E4ICD-interaction domain of TAB2 (Figure 2G).
These results indicate that TAB2 is a bifunctional molecule
with nonoverlapping binding sites for ErbB4 and N-CoR
and that it provides the critical link for the formation of
the ErbB4/TAB2/N-CoR complex.
ErbB4 Nuclear Signaling Affects Neural Precursor
Differentiation In Vitro
Neuronal precursors (NPs) express ErbB4 receptors (Fox
and Kornblum, 2005), but the functional relevance of
ErbB4 signaling in this population remained undefined.
We hypothesized that an E4ICD/TAB2/N-CoR complex
could be of biological significance for NPs in the central
nervous system. We first characterized the expression of
ErbB receptors in primary NP cultures obtained from
E14.5 rat cortices. These cells express only the ErbB4
JMa isoform (see Figure S1A in the Supplemental Data
available with this article online), which is readily activated
by NRG1 (Figure 3A), leading to its cleavage and release of
the 80 kDa E4ICD (Figure 3B). NPs also express ErbB2,
but not ErbB3 (Figures S1B and S1C). Since ErbB2 does
not bind to NRG1, these results indicate that any response
of NPs to NRG1 would require ErbB4, acting as either
a homodimer or an ErbB4/2 heterodimer.
To test whether ErbB4 endogenous to NPs interacts
with TAB2 and N-CoR, we performed immunoprecipita-
tion assays and found that NRG1 induces ErbB4 JMa
association with both endogenous TAB2 and N-CoR (Fig-
ure 3C). In addition, immunostaining showed that NRG1Cell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc. 187
Figure 2. Activated ErbB4 Induces TAB2 Nuclear Translocation and Interacts with N-CoR
(A) Activation of presenilin-sensitive isoform ErbB4 JMa induces nuclear translocation of TAB2. Whereas TAB2 immunoreactivity is excluded from the
nucleus in unstimulated cells expressing ErbB4 JMa, treatment with NRG1 for 2 hr results in TAB2 nuclear localization.
(B) NRG1-induced TAB2 nuclear translocation depends on ErbB4 activation and cleavage. Whereas treatment with NRG1 for 2 hr induces a dramatic
increase in TAB2 nuclear localization in cells expressing ErbB4 JMa, this translocation does not occur if cells are exposed to the presenilin inhibitor
DAPT 30 min before NRG1 stimulation or if cells express the cleavage-resistant isoform ErbB4 JMb or ErbB4 JMaKD (*p < 0.01). In this and all other
figures, error bars represent the standard error of the mean (SEM).
(C) ErbB4 JMa-induced TAB2 nuclear translocation represses transcription. Cells expressing ErbB4 JMa or JMb were cotransfected with a GAL4-
TAB2 fusion plasmid, a UAS-TK-luciferase reporter, and a TK-renilla reporter. Twenty-four hours later, cells were treated with DAPT or vehicle,
followed by stimulation with NRG1. Cells were lysed 24 hr later, and luciferase activity was measured (*p < 0.05).
(D) Activated ErbB4 interacts with N-CoR. Cells were transfected with WT or KD ErbB4, treated with NRG1 for 30 min, lysed, and subjected to
immunoprecipitation with an ErbB4 antibody followed by immunoblotting with N-CoR. Whole-cell lysates were immunoblotted with ErbB4 and
phosphotyrosine antibodies.
(E) TAB2 knockdown blocks ErbB4/N-CoR interaction. Cells transduced with control or TAB2 RNAi-expressing lentiviruses were treated and
processed as in (D).
(F) TAB2 C terminus is necessary for ErbB4/TAB2 interaction. ErbB4 was transfected together with FLAG-TAB2 (full-length or DC truncated protein).
Cells were treated and processed as in (D).
(G) TAB2 N terminus interacts with N-CoR. Cells were transfected with FLAG-TAB2 (full-length or DC or DN truncated proteins). After lysis and
immunoprecipitation with FLAG antibody, samples were immunoblotted with N-CoR antibody. Whole-cell lysates were also immunoblotted with
FLAG antibody to characterize the input. FLAG-TAB2, 88 kDa; FLAG-TAB2DC, 80 kDa; FLAG-TAB2DN, 18 kDa.promotes nuclear translocation of E4ICD, TAB2, and N-
CoR in virtually all NPs and that this depends on presenilin
activity (Figures 3D and 3E). Furthermore, lentivirus-medi-188 Cell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc.ated RNAi knockdown of TAB2 (Figure S2A) abolished the
NRG1-induced nuclear translocation of N-CoR, whereas
E4ICD nuclear translocation was not affected (Figure 3F).
Figure 3. Neural Precursors Express ErbB4 JMa, which,When Activated, Promotes the Formation and Nuclear Translocation of an
E4ICD/TAB2/N-CoR Complex
(A) NRG1 treatment (5 min) induces ErbB4 phosphorylation in neural precursors (NPs).
(B) NRG1 stimulation promotes E4ICD release from NPs. Cytoplasmic fractions of NPs either left untreated or stimulated with NRG1 were subjected to
western blot with ErbB4 antibodies. GADPH was used to control for loading.
(C) NRG1 induces ErbB4 JMa interactions with endogenous TAB2 and N-CoR in NPs. Cells were either left untreated or stimulated with NRG1 (30
min), lysed, immunoprecipitated with ErbB4 antibodies, and immunoblotted with N-CoR or TAB2 antibodies. Whole-cell lysates were blotted with the
same antibodies to show the input.
(D)NRG1treatment(2hr)stimulatesnucleartranslocationofendogenousE4ICD,TAB2,andN-CoRinNPsinapresenilin-dependentfashion(*p<0.01).
(E) Representative images of untreated NPs (control) or NPs stimulated with NRG1 stained with ErbB4, TAB2, or N-CoR (green). Nuclei are labeled
with Hoechst (blue).
(F) RNAi knockdown of TAB2 inhibits NRG1-dependent N-CoR nuclear translocation, while E4ICD nuclear shuttling is not affected. NPs were trans-
duced with control or TAB2 RNAi-expressing lentiviruses. Three days later, cells were treated and analyzed as in (D). Identical results were obtained
with two different RNAi constructs against TAB2 (*p < 0.01).These results indicate that E4ICD might be responsible
for nuclear shuttling of the E4ICD/TAB2/N-CoR complex
in NPs.
We then tested whether NRG1 stimulation of ErbB4
JMa nuclear signaling could regulate aspects of NP biol-ogy. Multipotent NPs can be isolated from embryonic
brains and maintained in culture in a proliferative undiffer-
entiated state or can be induced to adopt astrocytic or
neuronal fates by extracellular signaling molecules. These
molecules include ciliary neurotrophic factor (CNTF) andCell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc. 189
platelet-derived growth factor (PDGF), which induce
astrocytic or neuronal differentiation, respectively (Johe
et al., 1996). NRG1 stimulation did not induce the acquisi-
tion of either neuronal or astrocytic fates, as defined by
expression of the cell-type-specific markers glial fibrillary
acid protein (GFAP) and b-tubulin III (Figures 4A and 4B).
Similarly, NRG1 treatment did not modify NP survival or
proliferation (data not shown). Surprisingly, NRG1 antago-
nized the effects of CNTF on astrogenesis (Figure 4A)
without altering the ability of PDGF to induce NPs to adopt
a neuronal fate (Figure 4B). Furthermore, the presenilin in-
hibitor DAPT blocked the effect of NRG1 on CNTF-in-
duced astrogenesis (Figure 4A), indicating that cleavage
of the ErbB4 JMa receptor is required for this inhibition
of astrogenesis. These results suggest that activation
and cleavage of ErbB4 JMa after NRG1 stimulation might
contribute to maintenance of the NP pool in a neurogenic
state by preventing their differentiation into astrocytes.
To determine whether ErbB4 is the NRG1 receptor
implicated in this differentiation effect, we eliminated
ErbB4 expression in NPs using lentivirus-mediated RNAi
knockdown (Figure S2B). Infection with control lentivirus
did not alter the number of GFAP-positive astrocytes
found in untreated, NRG1-treated, and/or CNTF-treated
cultures (Figure 4C). In contrast, knockdown of ErbB4
completely abolished the ability of NRG1 to antagonize
the CNTF-induced astrogenesis (Figure 4C), indicating
that this receptor is essential for the NRG1-mediated
effect. Similar experiments carried out with TAB2 RNAi
produced identical results (Figure 4D), showing that TAB2
is required for the inhibition of the NRG1-dependent
inhibition of astrocyte differentiation.
E4ICD Nuclear Signaling Inhibits Astrogenesis
through Transcriptional Repression
of Astrocytic Genes
CNTF induction of NP differentiation into astrocytes in-
volves transcriptional activation of the GFAP promoter
(Bonni et al., 1997). Consistent with the ability of ErbB4
signaling to antagonize the effects of CNTF on astrocyte
differentiation, NRG1 had no effect on GFAP promoter
basal activity in a luciferase reporter assay in NPs, but it
significantly reduced the effects of CNTF on this pro-
moter’s activity (Figure 5A). This antagonistic effect of
NRG1 was blocked by the presenilin inhibitor DAPT (Fig-
ure 5A), expression of dominant-negative forms of prese-
nilin (Figure S3), and knockdown of ErbB4 (Figure 5B).
Importantly, NRG1 had similar effects on S100b, another
astrocyte protein. As with the GFAP promoter, NRG1
had no effect on the basal activity of a S100b-luciferase
reporter in NPs, it significantly reduced its activation by
CNTF, and this antagonistic effect of NRG1 was blocked
by the presenilin inhibitor DAPT (data not shown). These
results indicate that NRG1 inhibits astrocyte differentia-
tion through a transcriptional mechanism that depends
on presenilin-mediated cleavage of ErbB4.
The requirement of ErbB4 cleavage in the inhibition
of the CNTF effects was further investigated by testing190 Cell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc.whether ErbB4 variants with diverse sensitivities to prote-
ases could rescue the effects of NRG1 after RNAi knock-
down of endogenous ErbB4. ErbB4 receptors endoge-
nous to NPs were knocked down with ErbB4 RNAi, and
3 days later, cells were transfected with cDNAs encoding
one of the human ErbB4 juxtamembrane isoforms (HER4
JMa or JMb) or a mutant HER4 insensitive to presenilin
cleavage (HER4 JMa V673I), all of which are resistant to
the RNAi. Cells were cotransfected with the GFAP-lucifer-
ase and TK-renilla reporters. As shown in Figure 5B,
knockdown of endogenous ErbB4 abolished the antago-
nistic effect of NRG1 on GFAP promoter activity. Notably,
the antagonizing effect of NRG1 on CNTF-mediatedGFAP
activation was rescued only by expression of HER4
JMa, but not by the TACE-resistant HER4 JMb or the
Figure 4. NRG1-ErbB4 Signaling Inhibits Astrogenesis in
a Presenilin-Dependent Fashion
(A) NRG1 blocks CNTF-induced differentiation of NPs into astrocytes
in a presenilin-dependent manner. CNTF treatment (2 days) induced
NPs to differentiate into GFAP-expressing astrocytes. NRG1 treatment
did not change the number of GFAP+ cells but significantly reduced the
CNTF-mediated astrogenesis if applied 3 hr prior to CNTF. The NRG1
inhibition of CNTF-induced astrogenesis was blocked by addition of
DAPT 30 min prior to the other treatments (*p < 0.05).
(B) NRG1 has no effect on PDGF-induced neurogenesis. PDGF treat-
ment (4 days) increased the number of cells expressing the neuronal
marker b-tubulin III. Addition of NRG1 alone or before PDGF did not
alter the number of b-tubulin III+ cells.
(C and D) ErbB4 or TAB2 knockdown blocks NRG1 inhibition of astro-
genesis. NPs were transduced with control or TAB2 orErbB4RNAi-ex-
pressing lentiviruses. Three days later, cells were treated with CNTF
and/or NRG1 and analyzed as in (A). Similar results were obtained
with two different RNAi constructs against ErbB4 or TAB2 (*p < 0.05).
Figure 5. NRG1-ErbB4 Nuclear Signaling Inhibits GFAP Promoter Activation and Induces E4ICD Recruitment to this Promoter
(A) NRG1 blocks CNTF-induced GFAP promoter activation in a presenilin-dependent manner. NPs were cotransfected with GFAP-luciferase and
TK-renilla reporters. The next day, cells were treated with NRG1, CNTF, and/or DAPT. DAPT was added 30 min prior to NRG1. NRG1 was added
3 hr prior to CNTF. Six hours after CNTF addition, NPs were lysed and luciferase activity was measured (*p < 0.05).
(B) NRG1-mediated inhibition of CNTF-induced GFAP promoter activation depends on ErbB4. NPs were transduced with control or ErbB4 RNAi-ex-
pressing lentiviruses. After 3 days, cells were transfected, treated with NRG1 and/or CNTF, and analyzed as in (A). Similar results were obtained with
two different RNAi constructs against ErbB4 (*p < 0.05).
(C) Only the cleavable isoform HER4 JMa rescues the ErbB4 knockdown phenotype. ErbB4 endogenous to NPs was knocked down by RNAi. After 3
days, the human ErbB4 juxtamembrane isoforms (HER4 JMa or JMb) or the presenilin-resistant HER4 JMa V673I, which are resistant to the RNAi,
were transfected along with the reporters. Cells were then treated and processed as in (A) (*p < 0.05).
(D) Expression of activated E4ICD is sufficient to inhibit CNTF-induced GFAP promoter activation. NPs were cotransfected with empty vector, WT, or
KD LexA-E4ICD plasmids along with the reporters. The next day, cells were treated with CNTF and processed as in (A). Only wild-type E4ICD blocked
CNTF induction of the GFAP promoter; this blockade was presenilin independent (*p < 0.05).
(E) NRG1-mediated inhibition of CNTF-induced GFAP promoter activation depends on TAB2. NPs were transduced with control or TAB2 RNAi-
expressing lentiviruses. After 3 days, cells were transfected, treated, and analyzed as in (A). Similar results were obtained with two different RNAi
constructs against TAB2 (*p < 0.05).
(F) NRG1-mediated inhibition of CNTF-induced GFAP promoter activation requires the TAB2 C terminus. TAB2 (full-length or DC truncated) was
transfected along with the reporters. Cells were then treated and processed as in (A) (*p < 0.05).
(G) NRG1 induces E4ICD binding to theGFAP and S100b promoters in a presenilin-dependent manner. NPs were incubated for 30 min with vehicle or
DAPT before NRG1 treatment. After 6 hr, ChIP assays were performed with antibodies to ErbB4 or control IgG. PCR primers specific for GFAP or
S100b promoters were used. Primers against the first exon of HES1 serve as a negative control.Cell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc. 191
Figure 6. Precocious Astrogenesis in ErbB4 Knockout Developing Cortex
(A) Increased GFAP mRNA expression in E17.5 ErbB4/ HER4heart mouse cortex. In situ hybridization on coronal sections showing GFAP mRNA
expression in ErbB4+/and ErbB4/ HER4heart littermates. No signal was generated using a sense probe. lv = lateral ventricle. Bar = 50 mm.
(B) Increased GFAP protein expression in brains of E17.5 ErbB4/ HER4heart mice. GFAP immunoblot of whole-brain lysates of ErbB4/ HER4heart
embryos and their ErbB4+/ HER4heart littermates is shown. Three independent embryos are shown for each genotype. The membrane was stripped
and reblotted with GADPH antibody as a loading control.
(C) Increased expression of the astrocytic marker S100b in E17.5 ErbB4/ HER4heart mouse cortex. Coronal sections show S100b immunostaining
and nuclear staining in ErbB4+/ and ErbB4/ HER4heart littermates. lv = lateral ventricle. Bar = 50 mm.
(D) Only HER4 JMa rescues the ErbB4/ phenotype in slice cultures. Day 13.5 ErbB4/ HER4heart embryos were electroporated in utero with HER4
and GFP plasmids and dissected immediately. Forebrain slices were cultured for 4 days in vitro and processed for GFAP immunofluorescence.192 Cell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc.
presenilin-resistant HER4 JMa V673I (Figure 5C). These
results indicate that activation of the canonical signaling
by the ErbB4 RTK is not sufficient to exert this action. In
order for ErbB4 to block CNTF-mediated GFAP expres-
sion, cleavage of this RTK is absolutely necessary.
So far, our results indicated that E4ICD is necessary
for the effects of NRG1 on astrogenesis. To determine
whether E4ICD activity is sufficient to promote the GFAP
transcriptional repression, we used the LexA-E4ICD fu-
sion that, when expressed in mammalian cells, dimerizes,
becomes autophosphorylated, and interacts with TAB2
(Figure S4). Expression of LexA-E4ICD in NPs had no ef-
fect on the activity of the GFAP promoter, but it antago-
nized the CNTF-mediated GFAP activation (Figure 5D).
This effect of LexA-E4ICD was abolished when E4ICD
was rendered kinase dead but was not affected by the
presenilin blocker (Figure 5D). These results show that
E4ICD nuclear signaling is necessary and sufficient for
the inhibition of astrogenesis by NRG1.
To further investigate the roles of TAB2 in these pro-
cesses, we used RNAi to knock down its expression.
Similar to ErbB4, knockdown of TAB2 eliminated the an-
tagonistic effect of NRG1 on GFAP expression (Figure 5E).
Interestingly, overexpression of TAB2DC, the truncated
TAB2 that binds to N-CoR but not to ErbB4, also blocked
the antagonistic effect of NRG1 on CNTF-mediated
transcriptional activation of GFAP, whereas full-length
TAB2 did not (Figure 5F), indicating that TAB2DC acts
as a dominant-negative molecule by preventing formation
of the complex. These results indicate that repression of
the GFAP promoter by ErbB4 nuclear signaling requires
the presence of TAB2, which brings together E4ICD and
N-CoR.
The results described above suggested that E4ICD
could be part of the transcriptional repressor complex
that mediates the NRG1 inhibition of GFAP and S100b ex-
pression. To test this possibility, we used a chromatin im-
munoprecipitation (ChIP) assay. Immunoprecipitation with
ErbB4 antibodies showed that E4ICD associates with the
GFAP and S100b promoters in NPs, but only after treat-
ment with NRG1 (Figure 5G). Moreover, these associa-
tions were blocked by presenilin inhibition (Figure 5G).
The association of E4ICD with the glial promoters was
specific since normal rabbit immunoglobulin G (IgG) failed
to immunoprecipitate these promoters and ErbB4 anti-bodies did not precipitate a control promoter, HES1 (Fig-
ure 5G). These results indicate that NRG1 activation of
ErbB4 induces the presenilin-dependent release of E4ICD
and its recruitment to specific promoters, thereby regulat-
ing its transcriptional activity (see also Figure S5).
ErbB4 Is Necessary for the Correct Timing
of Astrogenesis In Vivo
The in vitro studies suggested that presenilin-dependent
ErbB4/TAB2/N-CoR nuclear signaling may regulate astro-
genesis in vivo. To test this possibility, we analyzed the ex-
pression of the astrocytic markers GFAP and S100b in the
cortex of ErbB4 knockout embryos using a line of mutant
mice that is rescued from early embryonic lethality by
reintroduction of ErbB4 in the heart (Tidcombe et al.,
2003). At E17.5, a time at which astrogenesis is just begin-
ning, the levels of GFAP mRNA and protein were dramat-
ically elevated in the cortical neurogenic layers of the
ErbB4/ HER4heart mice compared to their control litter-
mates (ErbB4+/ HER4heart; Figures 6A and 6B). Further-
more, expression of S100b was also increased in the
cortex of ErbB4/ HER4heart mice (Figure 6C).
The results described above clearly indicated that
ErbB4 signaling plays a critical role in controlling the onset
of astrogenesis in vivo but did not provide insights into the
importance of ErbB4 cleavage in this process. To investi-
gate this, we tested whether the alterations in GFAP ex-
pression in the ErbB4/ mice could be rescued by re-ex-
pression of the different ErbB4 isoforms using in utero
electroporation. cDNAs encoding either HER4 JMa or
HER4 JMb were transfected into the cortices of E13.5
ErbB4/ HER4heart mice together with a GFP expression
plasmid (Figure S6A). When embryos were dissected im-
mediately after transfection and slices of the forebrains
incubated for 4 days, expression of cleavage-sensitive
HER4 JMa, but not cleavage-resistant HER4 JMb, signif-
icantly reduced the GFAP expression levels (Figures 6D
and 6E). Identical results were obtained when the embryos
were allowed to develop in utero until E17.5 and then an-
alyzed histologically (Figures 6F and 6G). These results
indicate that canonical RTK signaling by ErbB4 is not suf-
ficient for normal control of GFAP expression in the devel-
oping cortex and that ErbB4 cleavage is necessary to
prevent precocious astrogenesis. Finally, to determine
whether ErbB4 nuclear signaling is sufficient to repressExpression of cleavage-sensitive HER4 JMa (arrow), but not cleavage-resistant HER4 JMb, significantly reduced the GFAP expression levels (red).
Bar = 100 mm.
(E) Quantitative analysis of GFAP expression in HER4 electroporated ErbB4/ HER4heart brains sliced and cultured for 4 days in vitro (n = 3,
*p < 0.05).
(F) Only HER4 JMa rescues the ErbB4/ phenotype in vivo. Day 13.5 ErbB4/ HER4heart embryos were electroporated in utero with HER4 and GFP
plasmids and allowed to develop until E17.5, when they were processed for GFAP immunofluorescence. Cortical coronal sections show that ex-
pression of cleavage-sensitive HER4 JMa (arrow), but not cleavage-resistant HER4 JMb, significantly reduced the GFAP expression levels (red).
Bar = 50 mm.
(G) Quantitative analysis of GFAP expression in HER4 electroporated ErbB4/ HER4heart embryos (n = 3, *p < 0.05).
(H) Expression of activated E4ICD is sufficient to inhibit astrogenesis in vivo. Day 13.5 wild-type embryos were electroporated in utero with LexA-
E4ICD constructs and GFP plasmids, allowed to develop until E18.5, and then analyzed for GFAP expression. Cortical coronal sections show that
expression of WT LexA-E4ICD (arrow), but not KD LexA-E4ICD, significantly reduced the GFAP expression levels (red). Bar = 50 mm.
(I) Quantitative analysis of GFAP expression in LexA-E4ICD electroporated wild-type embryos (n = 4, *p < 0.05).Cell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc. 193
astrogenesis in vivo, we tested whether expression of
E4ICD would reduce GFAP expression in wild-type
mice. Plasmids encoding either active or kinase-dead
LexA-E4ICD (Figure S6B) were transfected into the brains
of E13.5 wild-type embryos together with a GFP expres-
sion plasmid. After electroporation, the embryos were al-
lowed to continue developing in utero until E18.5. Similar
to what we observed in vitro (Figure 5D), expression of
wild-type LexA-E4ICD significantly reduced the levels of
GFAP compared to untransfected areas, whereas ki-
nase-dead LexA-E4ICD did not (Figures 6H and 6I). These
results show that E4ICD is necessary and sufficient to
regulate astrogenesis in the intact developing cortex.
DISCUSSION
We have described a novel mechanism by which an RTK
signals directly to the nucleus to regulate transcription
and influence cell fate choices of NPs (Figure 7). During
embryonic development, cortical NPs first generate
neurons and then produce, or themselves become, astro-
cytes (Sauvageot and Stiles, 2002). However, the signaling
mechanisms regulating the timing of these fate choices are
not well defined. Particularly, it is unclear whether astro-
genesis occurs later than neurogenesis because factors
that induce astrocyte formation are produced after those
inducing neurogenesis or because factors that inhibit as-
trogenesis are present at early stages of brain formation.
Our results support the latter possibility, indicating that,
during the early stages of brain development, NPs are ex-
posed simultaneously to extracellular signals that induce
neuronal and astrocyte production but that neurogenesis
is favored by presenilin-dependent ErbB4 nuclear signal-
ing that antagonizes the actions of astrogenesis-promot-
ing signals. At later stages, reduction in ErbB4 signaling,
most likely due to reduction in the levels of ErbB4 expres-
sion by the NPs (Fox and Kornblum, 2005), would favor the
generation of astrocytes. It is likely that alterations in the
timing of astrogenesis have effects on other aspects of
brain development in mice with defective ErbB4 signaling.
For example, it has been shown that ErbB4 knockout mice
have defects in tangential neuronal migration (Anton et al.,
2004; Flames et al., 2004). Interestingly, we have shown
that this type of migration is modulated by soluble signals
produced by astrocytes (Mason et al., 2001). Thus, some
of the defects in migration could be secondary to alter-
ations in astrocyte number or function.
Our results reveal a role for presenilin in neural develop-
ment, i.e., inhibition of astrogenesis via E4ICD release.
Based on these findings, we considered the possibility
that GFAP expression would be upregulated in presenilin
1/ mice as was the case for the ErbB4/ mice. We
used semiquantitative western blot analysis to measure
the levels of GFAP protein in the brains of E17.5 embryos.
Since presenilin 1/ mice have been shown to have
a smaller number of NPs (Wines-Samuelson and Shen,
2005), we normalized the levels of GFAP to those of the
NP marker nestin. Surprisingly, we found no differences194 Cell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc.in GFAP expression between presenilin 1/ mice and
their control littermates (S.P.S. and G.C., unpublished
data). Presenilin also plays important roles in Notch cleav-
age and function, and Notch1 signaling promotes astro-
genesis (Gaiano and Fishell, 2002). It is possible that the
combined loss of an inducer of astrogenesis (Notch) and
an inhibitor of astrogenesis (ErbB4 nuclear signaling) re-
sults in an apparently normal level of GFAP expression
in presenilin 1/ mice, but this merits further investiga-
tion. Nevertheless, these observations, together with our
in vitro studies, underscore the high degree of integration
necessary for NPs to interpret multiple signaling path-
ways, such as ErbB, Notch, and cytokine receptors, in
order to make adequate and timely fate choices.
We have also uncovered a role for presenilin-dependent
proteolytic cleavage of transmembrane proteins in cell
signaling, i.e., presenilin activity is required for transcrip-
tional repression and cell fate specification through cleav-
age of an RTK. Alterations in presenilin/g-secretase activ-
ity are associated with Alzheimer’s disease (AD) (Hutton
and Hardy, 1997), and ErbB4 is found at high levels sur-
rounding neuritic plaques in AD brains (Chaudhury et al.,
2003). Together, these observations suggest that changes
in presenilin-dependent ErbB4 signaling could be involved
in AD. One way in which this could occur is through cross-
talk between ErbB4 and the amyloid precursor protein
(APP). Presenilin-dependent cleavage of APP results in
the release of its intracellular domain (AICD), which has
been suggested to function in nuclear signaling and
Figure 7. Mechanism for the Regulation of NP Fate by ErbB4
Nuclear Signaling
ErbB4 activation by NRG1 promotes receptor phosphorylation and its
association with TAB2 and N-CoR. Ligand-induced ErbB4 cleavage by
TACE and presenilin allows for the nuclear translocation of the E4ICD/
TAB2/N-CoR complex. This complex binds to specific promoters
(GFAP and S100b), leading to their transcriptional repression and pre-
venting their activation by factors that induce astrocyte differentiation,
such as CNTF.
interacts with TAB2 and N-CoR. In transfected cells, AICD
has been shown to displace N-CoR from specific pro-
moters, resulting in gene derepression (Baek et al.,
2002). Thus, alterations in the balance between AICD
and E4ICD due to defects in APP and ErbB4 processing
could affect the transcriptional regulation of critical genes
and contribute to neurodegeneration. Furthermore, recent
work has demonstrated that complete loss of presenilin
activity in the forebrain leads to memory deficits, synaptic
dysfunction, and neurodegeneration without generation of
amyloid plaques (Saura et al., 2004). These results sug-
gest that some of the neurodegenerative processes that
might contribute to the severity of AD could be induced in-
dependently from abnormal amyloid peptide accumula-
tion. In this regard, ErbB4 signaling regulates several as-
pects of neuronal development and function beyond
neurogenesis, including dendrite morphology (Rieff and
Corfas, 2006), neurotransmitter receptor expression
(Ozaki et al., 1997; Rieff et al., 1999; Liu et al., 2001; Okada
and Corfas, 2004; Gu et al., 2005), and neuronal survival
(Li et al., 2003), all of which have been implicated in AD
pathology. Another observation suggesting that defects
in ErbB4 signaling could be involved in AD is that GFAP
and S100b expression are increased in AD (Beach et al.,
1989; Mrak and Griffin, 2001). Interestingly, S100b overex-
pression has been associated with increased susceptibil-
ity to b-amyloid toxicity (Craft et al., 2005). Therefore, de-
fects in presenilin-dependent ErbB4 signaling could lead
to increased S100b expression, which in turn could con-
tribute to AD by potentiating the degenerative process ini-
tiated by b-amyloid. Finally, an intriguing possibility is that
ErbB4 nuclear signaling could also regulate the differenti-
ation of adult NPs and that defects in this pathway might
result in alterations in adult neurogenesis, which may
also contribute to AD (Feng et al., 2001).
In summary, this study uncovers a signaling mechanism
for an RTK, demonstrates roles for presenilin in the devel-
oping nervous system, and provides insights into the
mechanisms that control the timing of astrogenesis in
the developing brain. Together, our results indicate that
further studies of ErbB4 nuclear signaling could provide
important insights into the mechanisms of brain develop-
ment and the causes of neurodegeneration. Furthermore,
our findings on ErbB4 nuclear signaling might be relevant
to other RTKs since other receptors undergo ligand-in-
duced shedding of their extracellular domain like ErbB4,
and this type of shedding has been shown to trigger
presenilin-dependent cleavage of numerous proteins
(Carpenter, 2003).
EXPERIMENTAL PROCEDURES
Antibodies
Antibodies used were mouse FLAG M2 and b-tubulin III (Sigma), GFAP
and nestin (Chemicon), and 4G10 (gift from O. Gjoerup and T. Roberts,
Dana-Farber Cancer Institute); rabbit TAB2 (ABR), ErbB4 (Santa Cruz),
N-CoR (Upstate), GFAP (DAKO), and LexA (Abcam); and goat TAB2
and S100b (Santa Cruz).Yeast Two-Hybrid Screen
Yeast two-hybrid screen was performed as described in Finley and
Brent (1996) (see Supplemental Experimental Procedures) with a bait
containing the entire E4ICD in an activated state and a cDNA expres-
sion library from rat E14 spinal cord and dorsal root ganglia.
Plasmids
Full-length cDNAs encoding human ErbB4 (HER4 JMa and JMb) were
cloned into pCDNA3. Kinase-dead HER JMaKD (K751M) and preseni-
lin-resistant HER4 V673I (Vidal et al., 2005) were generated by site-di-
rected mutagenesis. Wild-type and kinase-dead LexA-E4ICD were
cloned into pCDNA3 for expression in mammalian cells. The expres-
sion vector for FLAG-TAB2 was generated by cloning mouse TAB2
into pA1fg (gift from M. Lin and M. Greenberg, Children’s Hospital Bos-
ton). FLAG-TAB2DC (amino acids 1–628) and TAB2DN (amino acids
629–693) were generated by PCR and cloned into pA1fg. Wild-type
and dominant-negative presenilin plasmids (pZeo-PS1, pZeo-PS1
D257A, and pZeo-PS1-D385A) were a gift from D. Selkoe.
Cell Lines and Transfection
NIH 3T3 cells stably expressing HER4 JMa or JMb have been de-
scribed previously (Rio et al., 2000). HEK293 and NIH 3T3 cells were
cultured in DMEM (Invitrogen) containing 10% HI-FBS and 1% penicillin/
streptomycin. For transient transfections, cells were plated at 70%–
80% confluency on six-well or 10 cm plates, transfected using FuGENE
6 (Roche), and harvested 24 hr later. When indicated, cells were
treated with recombinant human neuregulin 1-b1 (NRG1, 1 nM, R&D
Systems). DAPT (1 mM, Calbiochem) was added 30 min before NRG1.
Coimmunoprecipitation and Western Blot
Cells were washed with cold PBS on ice and lysed in 20 mM Tris (pH
7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5
mM sodium pyrophosphate, 1 mM b-glycerolphosphate, 1 mM
Na3VO4, and 1 mM Pefabloc (Roche Applied Science). For immuno-
precipitations, lysates were precleared with agarose-conjugated nor-
mal IgG for 30 min and immunoprecipitated with agarose-conjugated
ErbB4 antibody (Santa Cruz) or FLAG antibody (M2, Sigma) overnight
at 4C. Samples were washed four times with lysis buffer before the
beads were resuspended in SDS sample buffer and boiled for 2 min.
Samples were subjected to SDS-PAGE. Western blotting was per-
formed by standard protocols and developed using ECL reagents
(Amersham).
Primary Neural Precursor Cultures
Timed-pregnant Long-Evans rats (Charles River Laboratories) were
treated according to the guidelines of the Animal Care and Use Com-
mittee of Children’s Hospital Boston. NPs were prepared from E14.5
rat telencephalons and cultured as described (Bonni et al., 1997).
For differentiation assays, cells were treated with CNTF (0.3 ng/ml,
Upstate) or PDGF (10 ng/ml, PeproTech).
RT-PCR Analysis of ErbB Receptors
After reverse transcription of total RNA from NPs, cDNA was amplified
by PCR using intron-spanning primers that differentiate between the
two ErbB4 juxtamembrane isoforms (Elenius et al., 1997). Primers se-
quences are provided in Supplemental Experimental Procedures.
Preparation of Cytoplasmic Fractions
Cytoplasmic fractions of NPs were prepared as described (Vidal et al.,
2005).
Immunofluorescence Analyses of Cells in Culture
Cells grown on glass coverslips were fixed with 4% paraformaldehyde
in PBS for 10 min, permeabilized in 0.1% Triton X-100 in PBS for
10 min, blocked with 5% BSA in PBS for 30 min, and then probed over-
night at 4C with primary antibodies diluted in blocking solution. The
coverslips were washed with PBS, and detection was performed usingCell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc. 195
the appropriate fluorescent secondary antibodies (Jackson Immuno-
Research) for 1 hr at room temperature. Nuclei were counterstained
with Hoechst 33342 (1 nM, Invitrogen). Coverslips were washed three
times for 10 min in PBS and mounted with VECTASHIELD (Vector
Laboratories). Images were obtained using a Zeiss LSM 510 confocal
microscope and taken with the same exposure parameters in each
experiment.
Luciferase Reporter Assays
Mouse TAB2 was cloned into pM plasmid (Invitrogen) to generate the
GAL4-TAB2 fusion protein. The MH100-TK-luciferase reporter con-
struct, containing five copies of the GAL4 DNA binding site and the
TK promoter upstream of a luciferase reporter gene, was provided
by R. Evans (Salk Institute). GFAP-luciferase and S100b-luciferase re-
porters were provided by M. Greenberg and B. Yankner (Children’s
Hospital Boston), respectively. The dual luciferase assay (Promega)
was performed according to the company’s recommendations.
Generation of Lentivirus for shRNA Expression
The vector pLL3.7 (from L. Van Parijs) was used to generate shRNAs.
The nucleotide sequences for the shRNAs are provided in Supplemen-
tal Experimental Procedures. Lentiviral production was performed as
described (Rubinson et al., 2003).
Chromatin Immunoprecipitation Assays
Chromatin immunoprecipitation was performed on NPs using the ChIP
Assay Kit (Upstate) according to supplier’s recommendations. PCR
was performed at 38 cycles as described (Hermanson et al., 2002).
(For primers, see Supplemental Experimental Procedures.)
ErbB4 Knockout Mice
We used ErbB4/ mice that were rescued from embryonic lethality
by cardiac expression of HER4 (Tidcombe et al., 2003). ErbB4/
HER4heart males were crossed with ErbB4+/ HER4heart females to
generate ErbB4/ (null) and ErbB4+/ (control) HER4heart embryos.
The use of the animals was approved by the Animal Care and Use
Committee of Children’s Hospital Boston.
In Situ Hybridization
In situ hybridization and preparation of digoxigenin-labeled riboprobes
were performed as previously described (Redwine and Armstrong,
1998). Riboprobes were generated using a GFAP 1.1 kb fragment
(gift from R. Skoff, Wayne State University).
In Utero Electroporation and Slice Cultures
Detailed methods for in utero electroporation and slice culture are
available in Supplemental Experimental Procedures.
Immunohistochemistry
Tissue sections were blocked with 0.1% Triton X-100, 5% BSA in PBS
for 30 min and stained overnight with GFAP (DAKO) or S100b antibody
(Santa Cruz). Primary antibody was then visualized using a Cy3- or
Cy5-conjugated secondary antibody (Jackson ImmunoResearch).
Nuclei were counterstained with Hoechst 33342 (1 nM, Invitrogen).
Fluorescent images were captured with a Nikon microscope (Eclipse
E800) using Spot advanced image software (version 3.4.4) or with
a Zeiss LSM 510 confocal microscope for quantitative analysis.
Quantification of GFAP Immunofluorescence
Confocal images of GFAP immunostaining in the areas adjacent to the
lateral ventricles were taken with the same exposure parameters for
each experiment. The same areas were imaged for GFP fluorescence.
The mean intensity of GFAP immunofluorescence in the transfected
(GFP+) and untransfected (GFP) regions was then calculated using
Photoshop CS (Adobe). The ratio of GFAP intensity (GFP+/GFP)
was calculated for each section. At least three independent embryos
were analyzed for each experimental condition.196 Cell 127, 185–197, October 6, 2006 ª2006 Elsevier Inc.Statistical Analysis
All data is presented as mean ± SEM. Statistical significance for neu-
ronal and astroglial differentiation assays was determined by c2. More
than 300 cells were analyzed for every condition in each of three inde-
pendent experiments. Statistical significance for nuclear translocation
of E4ICD, TAB2, and N-CoR was determined by c2, with more than 100
cells analyzed per experimental condition. Statistical significance for
GFAP quantitative analysis was determined by Student’s t test.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and six figures and can be found with this article online at http://
www.cell.com/cgi/content/full/127/1/185/DC1/.
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